What are the side effects of buspirone (Buspar)?

Side Effects of Buspirone (Buspar)

Buspirone's most common side effects include dizziness (12%), drowsiness (10%), nausea (8%), and headache (6%), with the medication generally well-tolerated and notably lacking the sedation and dependence risks associated with benzodiazepines. 1

Most Common Side Effects (≥5% incidence)

According to FDA-approved labeling from controlled clinical trials, the following adverse events occur most frequently and at higher rates than placebo: 1

Central Nervous System Effects

• Dizziness (12%) - the most common side effect, occurring 4 times more frequently than placebo (3%) 1
• Drowsiness (10%) - though notably similar to placebo rates (9%) 1
• Nervousness (5%) - occurring 5 times more than placebo (1%) 1
• Lightheadedness (3%) - not observed in placebo group 1

Gastrointestinal Effects

• Nausea (8%) - compared to 5% with placebo 1
• Dry mouth (3%) - similar to placebo (4%) 1

Other Common Effects

• Headache (6%) - twice the placebo rate (3%) 1
• Fatigue (4%) - equal to placebo 1
• Excitement (2%) - not seen with placebo 1

Discontinuation Rates

Approximately 10% of patients discontinued buspirone in premarketing trials due to adverse events, with the primary reasons being: 1

• CNS disturbances (3.4%): dizziness, insomnia, nervousness, drowsiness, lightheadedness 1
• GI disturbances (1.2%): primarily nausea 1
• Miscellaneous (1.1%): headache and fatigue 1

Less Common but Clinically Important Side Effects

Cardiovascular (Infrequent to Rare)

• Tachycardia/palpitations (1%) 1
• Syncope, hypotension, hypertension (infrequent) 1
• Rare: cerebrovascular accident, congestive heart failure, myocardial infarction 1

Psychiatric/Neurological (Infrequent)

• Dream disturbances (frequent) 1
• Depersonalization, dysphoria, euphoria, akathisia 1
• Hallucinations, involuntary movements, suicidal ideation, seizures 1
• Tremor (1%) 1
• Confusion (2%) 1

Sexual Function (Infrequent to Rare)

• Decreased or increased libido (infrequent) 1
• Delayed ejaculation and impotence (rare) 1

Other Systems

• EENT: Blurred vision (2%), tinnitus, sore throat, nasal congestion 1
• Musculoskeletal: Muscle aches/pains (1%), muscle cramps, spasms 1
• Dermatologic: Skin rash (1%), pruritus, flushing 1

Emerging Safety Signals from Real-World Data

Recent pharmacovigilance analysis of 1,744 adverse event reports identified several important findings: 2

Serious Concerns

• Serotonin syndrome (n=83) - a potentially life-threatening condition, particularly with drug interactions 2
• Suicide-related events - exhibited considerable safety signals 2
• Drug interactions (n=86) - second most common reported event 2

Abuse Potential (Novel Finding)

• Drug abuse (n=43), intentional overdose (n=30), elevated drug levels (n=17) suggest potential misuse risk 2
• Median time to adverse event onset: 10 days 2

Metabolic Effects

• Obesity (n=19) - a relatively rare but noteworthy signal requiring further attention 2

Comparative Safety Profile

Advantages Over Benzodiazepines

Meta-analysis data demonstrates buspirone's superior tolerability profile: 3

• Significantly less drowsiness than diazepam (32%), clorazepate (26%), lorazepam (58%), or alprazolam (43%) 3
• Less fatigue than all benzodiazepines 3
• Lower rates of depression compared to clorazepate, diazepam, or lorazepam 3
• No impotence (only occurred with clorazepate and lorazepam) 3

Specific Buspirone-Associated Effects

Buspirone shows higher rates of: 3

• Dizziness, headache, nervousness, lightheadedness 3
• Nausea and diarrhea (more than some benzodiazepines) 3
• Paresthesia, excitation, sweating/clamminess 3

Cognitive Effects (Potential Benefit)

Contrary to typical anxiolytic side effects, recent meta-analysis suggests buspirone may provide cognitive benefits: 4

• Significant improvement in visual learning and memory (g=0.49) 4
• Enhanced logical reasoning (g=0.42) and attention (g=0.37) 4
• Despite side effects of dizziness, constipation, and gastric distress, cognitive performance improved 4

Clinical Caveats

Dosing Considerations

• BID dosing (15mg twice daily) shows similar tolerability to TID dosing (10mg three times daily), except for higher palpitation rates (5% vs 1%) with BID 5
• Most adverse effects are mild to moderate in severity 3
• Effects typically emerge within the first few weeks of treatment 1

Special Populations

• Previous benzodiazepine exposure may affect tolerability and efficacy 6
• Patients switching from benzodiazepines may experience higher dropout rates 6

Postmarketing Reports

Rare but documented events include: 1

• Allergic reactions, angioedema, urticaria 1
• Extrapyramidal symptoms, dyskinesias (acute and tardive), parkinsonism 1
• Cogwheel rigidity, akathisia, restless leg syndrome 1
• Visual changes including tunnel vision 1